<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Alternate Name</th>
        <th class="naaccr-summary-header naaccr-borders">Item#</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1675</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">CoC</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1743-1743</td>
    </tr>
</table>

<br/><b>Description</b><br/>
Codes for the type of biological response modifier therapy given as part of the second course of treatment. Central registries currently collecting this data item should follow the <i>1998 ROADS Manual</i> coding instructions. The codes are the same as those for Immunotherapy, <i>1998 ROADS Manual</i>, p. 243. See also First Course Calc Method [1500].

<br/><br/><i>Note:</i> This data item is no longer supported by CoC (as of January 1, 2003).
